Company news

NIPRO Corporation news in 2026

NIPRO Corporation's news releases, calls and decks from 2026, newest first.

View company

Notice Regarding Conversion Results and Redemption of Euro-Yen Denominated Convertible Bonds Due 2026

September 15, 2026

[Summary]Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)

August 10, 2026

NIPRO Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States

July 30, 2026

Notice Concerning Expected Recording of Extraordinary Income from Sale of Investment Securities

July 29, 2026

Notice Concerning Changes in Subsidiary and Equity-Method Affiliate

June 26, 2026

Announcement of Investment by Development Bank of Japan Inc. in a U.S. Subsidiary of NIPRO

March 25, 2026

Notice Concerning Change in Depreciation Method

March 24, 2026

Announcement of Spryte Medical, a US Affiliate of NIPRO, First Participants Enrolled in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment

March 17, 2026

Notice Concerning the Establishment of the Record Date for the Year-End Dividend

March 11, 2026

Announcement of Expansion of Commercial Collaboration Between Gentuity LLC, a US Affiliate of NIPRO, and GE HealthCare

February 25, 2026

Notice Regarding the Establishment of the Nomination and Compensation Committee

February 25, 2026

Announcement of Avantec Vascular, a US Affiliate of NIPRO, Receives FDA 510(k) clearance of DVT-Focused Thrombectomy System

February 3, 2026

Decks in 2026